Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

Part of Topic

High risk pregnancy

Enigma Of EHPVO In Pregnancy : A Case Report

Dr. Hira Mardi , Senior Consultant, OBS- GYN ,Kinder Women’s Hospital and Fertility center,

Dr. Lavanya Sathyam, Consultant, BFMC Bangalore / Dr Sushitha C, MBBS, Medical Officer,. 

 

INTRODUCTION

  • Extrahepatic portal-vein obstruction (EHPVO) is a one of the causes of portal hypertension in pregnancy.
  • EHPVO is defined as obstruction of the extra hepatic portal vein with or without the involvement of the intrahepatic portal veins or splenic or superior mesenteric veins. 
  • The main risk in pregnant women with this condition is variceal bleeding, which may be life-threatening. 
  • We hereby report a case of pregnancy with pre-existing extrahepatic portal-vein obstruction (EHPVO) and its management.

PRESENTING COMPLAINTS

  • 37-year-old primigravida , IVF conception , 29 weeks and 2 days with gestational diabetes mellitus on insulin and gestational hypertension on antihypertensives.
  • Presenting complaints included acute febrile illness , pedal edema extending to thighs in the past 2 weeks with nausea, headache , myalgia and epigastric pain in the past 2 days.

PAST HISTORY 

  •  H/o  of Untreated chronic liver disease with Portal Vein thrombosis
  • H/o Pre- conceptional chronic thrombocytopenia 

VITALS AT ADMISSION  

  • PR - 90/min
  • BP- 130/75
  • Temp – Normal
  • GRBS - 251 mg/dl
  • Grade 2 bilateral pedal edema
  • Abdominal examination - 30 weeks, tense abdomen with abdominal wall edema , FHR -140/min

DIAGNOSTIC WORK UP  AND MANAGEMENT 

At Admission : 

  • Hb -12.8 gm/dl
  • Platelet count - 43000 cells/cu mm. 
  • LFT -  normal
  • Urine albumin 2 +

DAY -2 :

  • FWBS  (DAY -2 ) - normal growth of the fetus
  • Bilateral venous doppler of the lower limbs (DAY -2) – normal
  • 24 Hour urine albumin - negative for microalbuminuria
  • Maternal echo - concentric left ventricular hypertrophy with good left ventricular systolic function (LVEF- 55%)

DAY-3

  • Maternal USG abdomen for abdominal organs -  Chronic portal vein     thrombosis with chronic liver disease changes and mild to moderate splenomegaly. 

DAY - 4 :

  • 2 doses of steroids  i.m  24 hrs apart for lung maturity
  • Intravenous magnesium sulphate for neuroprotection

DAY – 6 :

  • Developed acute haematuria 
  • Shifted to ICU for further management
  • Protein Creatinine Ratio increased with uncontrolled sugars
  • Delivery by Emergency LSCS

 

OUTCOME AND FOLLOW UP 

  • Male baby , 2 Kg , Good Apgar ( LSCS)
  • 2 drains were inserted (1 subcutaneous, 1 intraperitoneal) in view of possible bleeding risk due to low platelets. On post POD- 1 : Platelet count improved, blood pressure stabilized and sugar levels normalized
  • POD – 3 :  Intraperitoneal drain removed
  • POD – 7 :   Discharged in good condition 

CONCLUSION 

  • A multidisciplinary approach including obstetricians, gastroenterologists, endocrinologist  and anaesthetists is essential to optimise the outcome. 
  • Preconception counselling is vital. 
  • Oesophageal and gastric varices should be treated in the prepregnant state. 
  • Anticoagulant therapy plays an important role and should be advocated in all patients

REFERENCES

  1. Subbaiah M, Kumar S, Roy KK, Sharma JB, Singh N. Extrahepatic portal-vein obstruction in pregnancy. Taiwan J Obstet Gynecol. 2015 Aug;54(4):394-7. 
  2. 2. Hosomi S, Oyama R, Isurugi C, Sato T, Baba T. Pregnancy Complicated by Extrahepatic Portal Vein Occlusion and Portal Vein Thrombosis: A Case Report. Cureus. 2024 Oct 26;16(10):e72457. 

 

 

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.